Olmecip Trio (Olmesartan/Hydrochlorothiazide/Amlodipine)
| Active Ingredient | Olmesartan/Amlodipine/Hydrochlorothiazide |
|---|---|
| Indication: | High blood pressure |
| Manufacturer: | Cipla Limited |
| Packaging | 10 Tablets in 1 Strip |
| Strength | 40mg/12.5mg/5mg |
| Delivery Time | 6 To 15 days |
Olmecip Trio is a triple-combination antihypertensive tablet containing Olmesartan (an ARB), Amlodipine (a calcium channel blocker), and Hydrochlorothiazide (a thiazide diuretic). It is prescribed for the treatment of high blood pressure (hypertension) when single or dual therapy is not sufficient. Olmesartan relaxes blood vessels by blocking angiotensin II, amlodipine widens arteries by reducing calcium flow, and hydrochlorothiazide removes excess salt and water from the body. This combination works together to provide comprehensive blood pressure control and reduce the risk of heart attack, stroke, and kidney damage. It is usually taken once daily. Common side effects include dizziness, fatigue, and increased urination.








There are no reviews yet.